Superiority analyses (intervention vs control group)
cancer stage
REGRESSION
The intervention and control groups were comparable in terms of baseline summary score and physical functioning (Multivariable linear regression analysis for health-related quality of life from baseline to 15 weeks intervention vs control group including confoundersEORTC quality-of-life score and functioning scales: higher score = better quality of life and/or functioning. EORTC symptom scales: higher score = worse symptoms. T1 = 15 weeks; B = unstandardized beta; SE = Cohen’s Clinical relevance according to guidelines of Cocks et al. (Multivariable analyses were controlled for histology, treatment, cancer stage, baseline score, and transfer sequence of the hospitals.n = 416.The summary score improved (to any degree) from baseline to 15 weeks after start of treatment among statistically significantly more patients in the intervention group than in the control group (62% vs 46%) and deteriorated among fewer patients (38% vs 54%; Proportion of patients with health-related quality of life changes at 15 weeks (T1) compared with baseline. For the clinically relevant change in physical functioning Cock et al. (After controlling for confounders, both the summary score (B = 4.85, 95% CI = 1.96 to 7.73, ES = 0.57; 